Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Biomolecules ; 10(6)2020 06 17.
Artículo en Inglés | MEDLINE | ID: mdl-32560534

RESUMEN

Linum usitatissimum biosynthesizes lignans and neolignans that are diet and medicinally valuable metabolites. In recent years, zinc oxide nanoparticles (ZnONPs) have emerged as potential elicitors for the enhanced biosynthesis of commercial secondary metabolites. Herein, we investigated the influence of biogenic ZnONPs on both seedlings and stem-derived callus of L. usitatissimum. Seedlings of L. usitatissimum grown on Murashige and Skoog (MS) medium supplemented with ZnONPs (1-1000 mg/L) presented the highest antioxidant activity, total phenolic content, total flavonoid content, peroxidase and superoxide dismutase activities at 500 mg/L, while the maximum plantlet length was achieved with 10 mg/L. Likewise, the high-performance liquid chromatography (HPLC) analysis revealed the enhanced production of secoisolariciresinol diglucoside, lariciresinol diglucoside, dehydrodiconiferyl alcohol glucoside and guaiacylglycerol-ß-coniferyl alcohol ether glucoside in the plantlets grown on the 500 mg/L ZnONPs. On the other hand, the stem explants were cultured on MS media comprising 1-naphthaleneacetic acid (1 mg/L) and ZnONPs (1-50 mg/L). The highest antioxidant and other activities with an enhanced rooting effect were noted in 25 mg/L ZnONP-treated callus. Similarly, the maximum metabolites were also accumulated in 25 mg/L ZnONP-treated callus. In both systems, the dose-dependent production of reactive oxygen species (ROS) was recorded, resulting in oxidative damage with a more pronounced toxic effect on in vitro cultures. Altogether, the results from this study constitute a first comprehensive view of the impact of ZnONPs on the oxidative stress and antioxidant responses in seedlings vs. in vitro cultures.


Asunto(s)
Antioxidantes/farmacología , Lino/efectos de los fármacos , Nanopartículas/química , Plantones/efectos de los fármacos , Óxido de Zinc/farmacología , Antioxidantes/química , Antioxidantes/metabolismo , Relación Dosis-Respuesta a Droga , Lino/química , Lino/metabolismo , Nanopartículas/metabolismo , Estrés Oxidativo/efectos de los fármacos , Óxido de Zinc/química , Óxido de Zinc/metabolismo
2.
PLoS One ; 15(6): e0233963, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32530961

RESUMEN

Eclipta alba L., also known as false daisy, is well known and commercially attractive plant with excellent hepatotoxic and antidiabetic activities. Light is considered a key modulator in plant morphogenesis and survival by regulating important physiological cascades. Current study was carried out to investigate growth and developmental aspects of E. alba under differential effect of multispectral lights. In vitro derived callus culture of E. alba was exposed to multispectral monochromatic lights under controlled aseptic conditions. Maximum dry weight was recorded in culture grown under red light (11.2 g/L) whereas negative effect was observed under exposure of yellow light on callus growth (4.87 g/L). Furthermore, red light significantly enhanced phenolics and flavonoids content (TPC: 57.8 mg/g, TFC: 11.1 mg/g) in callus cultures compared to rest of lights. HPLC analysis further confirmed highest accumulation of four major compounds i.e. coumarin (1.26 mg/g), eclalbatin (5.00 mg/g), wedelolactone (32.54 mg/g) and demethylwedelolactone (23.67 mg/g) and two minor compounds (ß-amyrin: 0.38 mg/g, luteolin: 0.39 mg/g) in red light treated culture whereas stigmasterol was found optimum (0.22 mg/g) under blue light. In vitro based biological activities including antioxidant, antidiabetic and lipase inhibitory assays showed optimum values in cultures exposed to red light, suggesting crucial role of these phytochemicals in the enhancement of the therapeutic potential of E. alba. These results clearly revealed that the use of multispectral lights in in vitro cultures could be an effective strategy for enhanced production of phytochemicals.


Asunto(s)
Antioxidantes/metabolismo , Eclipta/metabolismo , Eclipta/efectos de la radiación , Hipoglucemiantes/metabolismo , Fitoquímicos/metabolismo , Antioxidantes/química , Cumarinas/metabolismo , Eclipta/crecimiento & desarrollo , Flavonoides/metabolismo , Hipoglucemiantes/química , Luz , Fenoles/metabolismo , Fitoquímicos/química , Metabolismo Secundario/efectos de la radiación , Técnicas de Cultivo de Tejidos
3.
Arch Dermatol Res ; 309(10): 773-785, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28913623

RESUMEN

Syndromic ichthyosis is rare inherited disorders of cornification with varied disease complications. This disorder appears in seventeen subtypes associated with severe systematic manifestations along with medical, cosmetic and social problems. Syndromic ichthyosis with prominent hair abnormalities covers five major subtypes: Netherton syndrome, trichothiodystrophy, ichthyosis hypotrichosis syndrome, ichthyosis hypotrichosis sclerosing cholangitis and ichthyosis follicularis atrichia photophobia syndrome. These syndromes mostly prevail in high consanguinity states, with distinctive clinical features. The known pathogenic molecules involved in ichthyosis syndromes with prominent hair abnormalities include SPINK5, ERCC2, ERCC3, GTF2H5, MPLKIP, ST14, CLDN1 and MBTPS2. Despite underlying genetic origin, most of the health professionals solely rely on phenotypic expression of these disorders that leads to improper management of patients, hence making these patients living an orphanage life. After dermal features, association of other systems such as nervous system, skeletal system, hair abnormalities or liver problems may sometimes give clues for diagnosis but still leaving place for molecular screening for efficient diagnosis. In this paper, we have presented a review of ichthyosis syndrome with prominent hair abnormalities, with special emphasis on their updated genetic consequences and disease management. Additionally, we aim to update health professionals about the practice of molecular screening in ichthyosis syndromes for appropriate diagnosis and treatment.


Asunto(s)
Enfermedades del Cabello/terapia , Cabello/anomalías , Ictiosis/terapia , Fotofobia/terapia , Enfermedades Raras/terapia , Consanguinidad , Fármacos Dermatológicos/uso terapéutico , Exoma/genética , Pruebas Genéticas/métodos , Enfermedades del Cabello/diagnóstico , Enfermedades del Cabello/etiología , Enfermedades del Cabello/mortalidad , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Ictiosis/diagnóstico , Ictiosis/etiología , Ictiosis/mortalidad , Mutación , Fenotipo , Fotofobia/diagnóstico , Fotofobia/etiología , Fotofobia/mortalidad , Fototerapia/métodos , Enfermedades Raras/diagnóstico , Enfermedades Raras/etiología , Enfermedades Raras/mortalidad , Síndrome
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...